Stratos Wealth Partners, Ltd. Sesen Bio, Inc. Transaction History

Stratos Wealth Partners, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$0.49 - $0.61 $63 - $79	-130 Reduced 0.03%	413,000 $0
Q2 2022 Jul 22, 2022	BUY	$0.38 - $0.89 $8,954 - $20,972	23,565 Added 6.05%	413,130 $335,000
Q1 2022 Apr 26, 2022	BUY	$0.58 - $0.86 $56,877 - $84,335	98,065 Added 33.64%	389,565 $235,000
Q4 2021 Jan 14, 2022	SELL	$0.73 - $1.28 $71,102 - $124,672	-97,400 Reduced 25.04%	291,500 $238,000
Q3 2021 Oct 19, 2021	BUY	$0.77 - $4.91 $28,028 - $178,724	36,400 Added 10.33%	388,900 $308,000
Q2 2021 Jul 19, 2021	BUY	$2.18 - $4.66 $129,710 - $277,270	59,500 Added 20.31%	352,500 $1.63 Million
Q1 2021 Apr 27, 2021	BUY	$1.3 - $3.24 $38,610 - $96,228	29,700 Added 11.28%	293,000 $762,000
Q4 2020 Jan 29, 2021	BUY	$1.01 - $1.77 $63,933 - $112,041	63,300 Added 31.65%	263,300 $355,000
Q3 2020 Oct 29, 2020	SELL	$0.67 - $1.4 $1,340 - $2,800	-2,000 Reduced 0.99%	200,000 $280,000
Q2 2020 Jul 28, 2020	BUY	$0.52 - $0.87 $105,040 - $175,740	202,000 New	202,000 $145,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.